We are live on ! Find out more
Chevy Chase Trust

Chevy Chase Trust Portfolio holdings

AUM $34.7B
1-Year Est. Return 29.45%
This Fund
S&P 500
This Quarter Est. Return
+9.99%
1 Year Est. Return
+29.45%
3 Year Est. Return
+102.04%
5 Year Est. Return
+142.29%
10 Year Est. Return
+523.99%
AUM
$23.5B
AUM Growth
+$107M
Cap. Flow
-$1.64B
Cap. Flow %
-6.97%
Top 10 Hldgs %
24.51%
Holding
663
New
33
Increased
22
Reduced
548
Closed
15

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$78.9M
3
AMZN icon
Amazon
AMZN
+$45.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$45.1M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$43.2M

Sector Composition

Rank Sector Weight
1 Technology 24.13%
2 Healthcare 15.8%
3 Financials 13.85%
4 Consumer Discretionary 8.66%
5 Consumer Staples 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$465B
$172M 0.73%
1,061,814
-61,737
-5% -$9.47M
PFE icon
27
Pfizer
PFE
$143B
$170M 0.72%
3,319,582
-200,420
-6% -$9.61M
MRK icon
28
Merck
MRK
$322B
$169M 0.72%
1,521,081
-88,211
-5% -$9.02M
LLY icon
29
Eli Lilly
LLY
$1.08T
$168M 0.71%
459,400
-27,731
-6% -$9.83M
NKE icon
30
Nike
NKE
$64.1B
$163M 0.69%
1,395,563
-181,458
-12% -$18.3M
META icon
31
Meta Platforms (Facebook)
META
$1.49T
$158M 0.67%
1,310,937
-104,517
-7% -$12.3M
VZ icon
32
Verizon
VZ
$197B
$153M 0.65%
3,886,312
-998,533
-20% -$37.6M
CVS icon
33
CVS Health
CVS
$135B
$153M 0.65%
1,640,176
-179,615
-10% -$17.3M
KO icon
34
Coca-Cola
KO
$383B
$151M 0.64%
2,375,130
-135,312
-5% -$8.17M
DIS icon
35
Walt Disney
DIS
$171B
$141M 0.6%
1,619,998
-183,698
-10% -$17.6M
BAC icon
36
Bank of America
BAC
$429B
$135M 0.57%
4,066,900
-255,957
-6% -$8.82M
SHEL icon
37
Shell
SHEL
$244B
$131M 0.56%
2,306,362
-237,257
-9% -$13.1M
AVGO icon
38
Broadcom
AVGO
$1.76T
$131M 0.56%
2,340,250
-136,600
-6% -$6.85M
PI icon
39
Impinj
PI
$4.24B
$130M 0.55%
1,188,224
-216,297
-15% -$22.8M
EL icon
40
Estee Lauder
EL
$30.4B
$126M 0.54%
509,322
-50,625
-9% -$11.3M
TMO icon
41
Thermo Fisher Scientific
TMO
$214B
$126M 0.53%
228,261
-12,984
-5% -$6.88M
DHR icon
42
Danaher
DHR
$138B
$124M 0.53%
526,006
-27,328
-5% -$6.33M
TJX icon
43
TJX Companies
TJX
$179B
$121M 0.51%
1,520,473
-15,060
-1% -$1.11M
CSCO icon
44
Cisco
CSCO
$443B
$117M 0.5%
2,456,682
-196,339
-7% -$8.94M
WMT icon
45
Walmart Inc
WMT
$909B
$116M 0.49%
2,454,477
-177,951
-7% -$8.45M
MCD icon
46
McDonald's
MCD
$193B
$116M 0.49%
439,957
-27,864
-6% -$7.35M
ABT icon
47
Abbott
ABT
$187B
$115M 0.49%
1,050,629
-68,387
-6% -$7.08M
ISRG icon
48
Intuitive Surgical
ISRG
$127B
$113M 0.48%
426,941
-18,150
-4% -$4.43M
CDNS icon
49
Cadence Design Systems
CDNS
$91.6B
$113M 0.48%
703,359
-37,165
-5% -$5.94M
LMT icon
50
Lockheed Martin
LMT
$131B
$101M 0.43%
206,810
-11,120
-5% -$5.17M

Similar funds

Chevy Chase Trust's Q4 2022 Portfolio in Review

As of Q4 2022, Chevy Chase Trust held 663 positions worth $23.5B, up 0.46% from $23.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Chevy Chase Trust withdrew a net $1.64B in Q4 2022, closing 15 positions and reducing 548 holdings. Its most notable exit was Twitter, Inc., an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Chevy Chase Trust opened a new position in Snowflake worth $12.1M.

  • Chevy Chase Trust's largest Q4 2022 buy was Snowflake: 84,323 shares worth $12.1M.
  • Chevy Chase Trust added most to Vertex Pharmaceuticals in Q4 2022, an estimated $18.1M increase.
  • Chevy Chase Trust's biggest Q4 2022 reduction was Apple, cutting an estimated $120M.
  • Chevy Chase Trust fully exited Twitter, Inc. in Q4 2022, selling an estimated $18M.
  • Chevy Chase Trust's ten largest holdings make up 25% of its $23.5B portfolio in Q4 2022.
  • Chevy Chase Trust opened 33 new positions and closed 15 in Q4 2022.
  • Chevy Chase Trust's portfolio value rose 0.46% quarter-over-quarter to $23.5B.

Based on Chevy Chase Trust's 13F filing for Q4 2022, filed 9 Feb 2023.